Endocannabinoid-Mediated Plasticity in Nucleus Accumbens Controls Vulnerability to Anxiety after Social Defeat Stress

Cell Reports

Volumn 16, Issue 5, 2016, Pages 1237-1242

  Bosch Bouju, Clémentine ^a,b   Larrieu, Thomas ^a,b   Linders, Louisa ^a,b   Manzoni, Olivier J ^c,d,e   Layé, Sophie ^a,b  

^a NutriNeuro Bordeaux University   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

^d INSERM   (France)

^e Turing Center for Living Systems CENTURI Aix Marseille University   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ENDOCANNABINOID; ACYLGLYCEROL; ARACHIDONIC ACID DERIVATIVE; GLYCERYL 2-ARACHIDONATE;

ADAPTIVE BEHAVIOR; ADULT; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; CHRONIC STRESS; CONTROLLED STUDY; EMOTIONALITY; MOUSE; NERVE CELL PLASTICITY; NEUROMODULATION; NONHUMAN; NUCLEUS ACCUMBENS; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SOCIAL STRESS; SPIKE TIMING DEPENDENT PLASTICITY; ANIMAL; C57BL MOUSE; DISEASE MODEL; EMOTION; MALE; MENTAL STRESS; METABOLISM; PHYSIOLOGY; SOCIAL BEHAVIOR;

ANIMALS; ANXIETY; ARACHIDONIC ACIDS; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; EMOTIONS; ENDOCANNABINOIDS; GLYCERIDES; MALE; MICE; MICE, INBRED C57BL; NEURONAL PLASTICITY; NUCLEUS ACCUMBENS; SOCIAL BEHAVIOR; STRESS, PSYCHOLOGICAL;

EID: 84989950664     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2016.06.082     Document Type: Article

References (45)

1. Abbott, L.F., Nelson, S.B., Synaptic plasticity: taming the beast. Nat. Neurosci. 3:Suppl (2000), 1178–1183.
2. Bagot, R.C., Parise, E.M., Peña, C.J., Zhang, H.-X., Maze, I., Chaudhury, D., Persaud, B., Cachope, R., Bolaños-Guzmán, C.A., Cheer, J.F., et al. Ventral hippocampal afferents to the nucleus accumbens regulate susceptibility to depression. Nat. Commun., 6, 2015, 7062.
3. Berton, O., McClung, C.A., Dileone, R.J., Krishnan, V., Renthal, W., Russo, S.J., Graham, D., Tsankova, N.M., Bolanos, C.A., Rios, M., et al. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 311 (2006), 864–868.
4. Bluett, R.J., Gamble-George, J.C., Hermanson, D.J., Hartley, N.D., Marnett, L.J., Patel, S., Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation. Transl. Psychiatry, 4, 2014, e408.
5. Calhoon, G.G., Tye, K.M., Resolving the neural circuits of anxiety. Nat. Neurosci. 18 (2015), 1394–1404.
6. Castillo, P.E., Younts, T.J., Chávez, A.E., Hashimotodani, Y., Endocannabinoid signaling and synaptic function. Neuron 76 (2012), 70–81.
7. Duval, E.R., Javanbakht, A., Liberzon, I., Neural circuits in anxiety and stress disorders: a focused review. Ther. Clin. Risk Manag. 11 (2015), 115–126.
8. Fino, E., Paille, V., Cui, Y., Morera-Herreras, T., Deniau, J.-M., Venance, L., Distinct coincidence detectors govern the corticostriatal spike timing-dependent plasticity. J. Physiol. 588 (2010), 3045–3062.
9. Francis, T.C., Chandra, R., Friend, D.M., Finkel, E., Dayrit, G., Miranda, J., Brooks, J.M., Iñiguez, S.D., O'Donnell, P., Kravitz, A., Lobo, M.K., Nucleus accumbens medium spiny neuron subtypes mediate depression-related outcomes to social defeat stress. Biol. Psychiatry 77 (2015), 212–222.
10. Glangetas, C., Girard, D., Groc, L., Marsicano, G., Chaouloff, F., Georges, F., Stress switches cannabinoid type-1 (CB1) receptor-dependent plasticity from LTD to LTP in the bed nucleus of the stria terminalis. J. Neurosci. 33 (2013), 19657–19663.
11. Golden, S.A., Covington, H.E. 3rd, Berton, O., Russo, S.J., A standardized protocol for repeated social defeat stress in mice. Nat. Protoc. 6 (2011), 1183–1191.
12. Gorzalka, B.B., Hill, M.N., Integration of endocannabinoid signaling into the neural network regulating stress-induced activation of the hypothalamic-pituitary-adrenal axis. Curr. Top. Behav. Neurosci. 1 (2009), 289–306.
13. Gray, J.M., Vecchiarelli, H.A., Morena, M., Lee, T.T.Y., Hermanson, D.J., Kim, A.B., McLaughlin, R.J., Hassan, K.I., Kühne, C., Wotjak, C.T., et al. Corticotropin-releasing hormone drives anandamide hydrolysis in the amygdala to promote anxiety. J. Neurosci. 35 (2015), 3879–3892.
14. Hill, M.N., Gorzalka, B.B., The endocannabinoid system and the treatment of mood and anxiety disorders. CNS Neurol. Disord. Drug Targets 8 (2009), 451–458.
15. Hill, M.N., Patel, S., Translational evidence for the involvement of the endocannabinoid system in stress-related psychiatric illnesses. Biol. Mood Anxiety Disord., 3, 2013, 19.
16. Hill, M.N., Tasker, J.G., Endocannabinoid signaling, glucocorticoid-mediated negative feedback, and regulation of the hypothalamic-pituitary-adrenal axis. Neuroscience 204 (2012), 5–16.
17. Hill, M.N., Patel, S., Carrier, E.J., Rademacher, D.J., Ormerod, B.K., Hillard, C.J., Gorzalka, B.B., Downregulation of endocannabinoid signaling in the hippocampus following chronic unpredictable stress. Neuropsychopharmacology 30 (2005), 508–515.
18. Hill, M.N., Miller, G.E., Carrier, E.J., Gorzalka, B.B., Hillard, C.J., Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress. Psychoneuroendocrinology 34 (2009), 1257–1262.
19. Hillard, C.J., Weinlander, K.M., Stuhr, K.L., Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence. Neuroscience 204 (2012), 207–229.
20. Hodes, G.E., Pfau, M.L., Leboeuf, M., Golden, S.A., Christoffel, D.J., Bregman, D., Rebusi, N., Heshmati, M., Aleyasin, H., Warren, B.L., et al. Individual differences in the peripheral immune system promote resilience versus susceptibility to social stress. Proc. Natl. Acad. Sci. USA 111 (2014), 16136–16141.
21. Jenniches, I., Ternes, S., Albayram, O., Otte, D.M., Bach, K., Bindila, L., Michel, K., Lutz, B., Bilkei-Gorzo, A., Zimmer, A., Anxiety, stress, and fear response in mice with reduced endocannabinoid levels. Biol. Psychiatry 79 (2016), 858–868.
22. Jung, K.-M., Sepers, M., Henstridge, C.M., Lassalle, O., Neuhofer, D., Martin, H., Ginger, M., Frick, A., DiPatrizio, N.V., Mackie, K., et al. Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome. Nat. Commun., 3, 2012, 1080.
23. Katona, I., Freund, T.F., Multiple functions of endocannabinoid signaling in the brain. Annu. Rev. Neurosci. 35 (2012), 529–558.
24. Krishnan, V., Han, M.-H., Graham, D.L., Berton, O., Renthal, W., Russo, S.J., Laplant, Q., Graham, A., Lutter, M., Lagace, D.C., et al. Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell 131 (2007), 391–404.
25. Lafourcade, M., Larrieu, T., Mato, S., Duffaud, A., Sepers, M., Matias, I., De Smedt-Peyrusse, V., Labrousse, V.F., Bretillon, L., Matute, C., et al. Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions. Nat. Neurosci. 14 (2011), 345–350.
26. Larrieu, T., Hilal, M.L., Fourrier, C., De Smedt-Peyrusse, V., Sans, N., Capuron, L., Layé, S., Nutritional omega-3 modulates neuronal morphology in the prefrontal cortex along with depression-related behaviour through corticosterone secretion. Transl. Psychiatry, 4, 2014, e437.
27. Letzkus, J.J., Kampa, B.M., Stuart, G.J., Does spike timing-dependent synaptic plasticity underlie memory formation?. Clin. Exp. Pharmacol. Physiol. 34 (2007), 1070–1076.
28. Levita, L., Hoskin, R., Champi, S., Avoidance of harm and anxiety: a role for the nucleus accumbens. Neuroimage 62 (2012), 189–198.
29. Mangieri, R.A., Piomelli, D., Enhancement of endocannabinoid signaling and the pharmacotherapy of depression. Pharmacol. Res. 56 (2007), 360–366.
30. Marsicano, G., Wotjak, C.T., Azad, S.C., Bisogno, T., Rammes, G., Cascio, M.G., Hermann, H., Tang, J., Hofmann, C., Zieglgänsberger, W., et al. The endogenous cannabinoid system controls extinction of aversive memories. Nature 418 (2002), 530–534.
31. McEwen, B.S., Bowles, N.P., Gray, J.D., Hill, M.N., Hunter, R.G., Karatsoreos, I.N., Nasca, C., Mechanisms of stress in the brain. Nat. Neurosci. 18 (2015), 1353–1363.
32. McLaughlin, R.J., Hill, M.N., Gorzalka, B.B., A critical role for prefrontocortical endocannabinoid signaling in the regulation of stress and emotional behavior. Neurosci. Biobehav. Rev. 42 (2014), 116–131.
33. Mechoulam, R., Parker, L.A., The endocannabinoid system and the brain. Annu. Rev. Psychol. 64 (2013), 21–47.
34. Morena, M., Patel, S., Bains, J.S., Hill, M.N., Neurobiological interactions between stress and the endocannabinoid system. Neuropsychopharmacology 41 (2016), 80–102.
35. Pickel, V.M., Chan, J., Kash, T.L., Rodríguez, J.J., MacKie, K., Compartment-specific localization of cannabinoid 1 (CB1) and mu-opioid receptors in rat nucleus accumbens. Neuroscience 127 (2004), 101–112.
36. Qin, Z., Zhou, X., Pandey, N.R., Vecchiarelli, H.A., Stewart, C.A., Zhang, X., Lagace, D.C., Brunel, J.M., Béïque, J.-C., Stewart, A.F.R., et al. Chronic stress induces anxiety via an amygdalar intracellular cascade that impairs endocannabinoid signaling. Neuron 85 (2015), 1319–1331.
37. Robbe, D., Kopf, M., Remaury, A., Bockaert, J., Manzoni, O.J., Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens. Proc. Natl. Acad. Sci. USA 99 (2002), 8384–8388.
38. Shin, S., Kwon, O., Kang, J.I., Kwon, S., Oh, S., Choi, J., Kim, C.H., Kim, D.G., mGluR5 in the nucleus accumbens is critical for promoting resilience to chronic stress. Nat. Neurosci. 18 (2015), 1017–1024.
39. Shonesy, B.C., Bluett, R.J., Ramikie, T.S., Báldi, R., Hermanson, D.J., Kingsley, P.J., Marnett, L.J., Winder, D.G., Colbran, R.J., Patel, S., Genetic disruption of 2-arachidonoylglycerol synthesis reveals a key role for endocannabinoid signaling in anxiety modulation. Cell Rep. 9 (2014), 1644–1653.
40. Steiner, M.A., Wanisch, K., Monory, K., Marsicano, G., Borroni, E., Bächli, H., Holsboer, F., Lutz, B., Wotjak, C.T., Impaired cannabinoid receptor type 1 signaling interferes with stress-coping behavior in mice. Pharmacogenomics J. 8 (2008), 196–208.
41. Vialou, V., Robison, A.J., Laplant, Q.C., Covington, H.E. 3rd, Dietz, D.M., Ohnishi, Y.N., Mouzon, E., Rush, A.J. 3rd, Watts, E.L., Wallace, D.L., et al. DeltaFosB in brain reward circuits mediates resilience to stress and antidepressant responses. Nat. Neurosci. 13 (2010), 745–752.
42. Vinod, K.Y., Hungund, B.L., Role of the endocannabinoid system in depression and suicide. Trends Pharmacol. Sci. 27 (2006), 539–545.
43. Wamsteeker, J.I., Kuzmiski, J.B., Bains, J.S., Repeated stress impairs endocannabinoid signaling in the paraventricular nucleus of the hypothalamus. J. Neurosci. 30 (2010), 11188–11196.
44. Zhang, Z., Wang, W., Zhong, P., Liu, S.J., Long, J.Z., Zhao, L., Gao, H.Q., Cravatt, B.F., Liu, Q.S., Blockade of 2-arachidonoylglycerol hydrolysis produces antidepressant-like effects and enhances adult hippocampal neurogenesis and synaptic plasticity. Hippocampus 25 (2015), 16–26.
45. Zhong, P., Wang, W., Pan, B., Liu, X., Zhang, Z., Long, J.Z., Zhang, H.T., Cravatt, B.F., Liu, Q.S., Monoacylglycerol lipase inhibition blocks chronic stress-induced depressive-like behaviors via activation of mTOR signaling. Neuropsychopharmacology 39 (2014), 1763–1776.